Stay updated with breaking news from Viveve System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patent further strengthens Viveve's novel dual-energy technology intellectual property portfolio as company plans for completion of pivotal PURSUIT clinical trialENGLEWOOD, CO / ACCESSWIRE / December 1
Patent issuance further strengthens Viveve's intellectual property portfolio for the treatment of female stress urinary incontinenceENGLEWOOD, CO / ACCESSWIRE / October 4, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE)
New branding reflects Company's vision to be the leader in the treatment of Stress Urinary Incontinence in WomenCompletion of PURSUIT follow-up visits anticipated by the end of 2022 with topline results
Electromed (NYSE:ELMD – Get Rating) and Viveve Medical (NASDAQ:VIVE – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Earnings & Valuation This table compares Electromed and Viveve Medical’s […]
Company Overview Viveve Medical Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories. The Geneveve is indicated for use in general procedures for electrocoagulation and hemostasis in the US. The firm markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada,...